As of November 6, 2026, Scribe Therapeutics, Inc. is a publicly traded company (Nasdaq: SCTX). The largest holder reporting an active stake on Schedule 13D is Avoro Capital Advisors LLC, at 16.37%. No bankruptcy or receivership appears in its SEC Form 8-K filings. Passive holders reporting on Schedule 13G include RA Capital (9.6%) (Schedule 13D, July 30, 2026).
Is this your company?
About to sign with, pay or invest in Scribe Therapeutics, Inc.? See the free Snapshot first.
Free to see. No signup.
Is Scribe Therapeutics, Inc. a real, registered company?
- Scribe Therapeutics Inc. files with the SEC under CIK 1853921 (its SEC filings).
- Its shares are listed under the ticker SCTX on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in Alameda, California, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Scribe Therapeutics Inc. in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names RA Capital (filed 2026-08-03).
Who are Scribe Therapeutics, Inc.'s owners and officers?
Scribe Therapeutics, Inc.: incorporated in Delaware; business address in Alameda, California; industry Biological Products, (No Diagnostic Substances) (Schedule 13G, 2026-08-03).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G, 2026-08-03 | Ra Capital Management, L.P. | 9.6% |
| Schedule 13D, 2026-07-30 | Eli Lilly & Co | 7.3% |
| Schedule 13D, 2026-07-30 | Avoro Capital Advisors LLC | 16.37% |
| Schedule 13D, 2026-07-29 | Orbimed Advisors LLC | 7.2% |
Questions about who owns Scribe Therapeutics, Inc.
Who owns Scribe Therapeutics, Inc.?
On this page, 4 holders' latest ownership filings report 5% or more of Scribe Therapeutics, Inc.: Avoro Capital Advisors LLC (16.37%, Schedule 13D, filed 2026-07-30), Ra Capital Management, L.P. (9.6%, Schedule 13G, filed 2026-08-03), Eli Lilly & Co (7.3%, Schedule 13D, filed 2026-07-30) and Orbimed Advisors LLC (7.2%, Schedule 13D, filed 2026-07-29).
Who are the largest shareholders of Scribe Therapeutics, Inc.?
By the share each holder's latest filing reports, the largest holders of Scribe Therapeutics, Inc. on this page are Avoro Capital Advisors LLC (16.37%), Ra Capital Management, L.P. (9.6%) and Eli Lilly & Co (7.3%).
When did Avoro Capital Advisors LLC buy into Scribe Therapeutics, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Avoro Capital Advisors LLC on this page is the Schedule 13D, filed 2026-07-30, reporting 16.37%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 4 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Scribe Therapeutics, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Scribe Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Scribe Therapeutics, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
11 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own Scribe Therapeutics, Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , a director and 10% owner: 3,088,888 shares (16.3% of shares outstanding), held indirectly (the form names the holder only in its footnotes), on a joint filing (Form 4, 2026-07-28).
- Avoro Capital Advisors LLC, a director and 10% owner: 3,088,888 shares (16.3% of shares outstanding), held indirectly (the form names the holder only in its footnotes), on a joint filing (Form 4, 2026-07-28).
- Avoro Ventures LLC, a director: 3,088,888 shares (16.3% of shares outstanding), held indirectly (the form names the holder only in its footnotes), on a joint filing (Form 4, 2026-07-28).
- AH Equity Partners Bio III, L.L.C., a 10% owner: 3,082,725 shares (16.3% of shares outstanding), held indirectly through By AH Bio Fund II, L.P. and 1 other, on a joint filing (Form 4, 2026-07-29).
- AH Equity Partners Bio II, L.L.C., a 10% owner: 3,082,725 shares (16.3% of shares outstanding), held indirectly through By AH Bio Fund II, L.P. and 1 other, on a joint filing (Form 4, 2026-07-29).
Shares outstanding: 18,931,680 as of 2026-08-31, from the company's latest SEC cover page.
How much has Scribe Therapeutics, Inc. raised?
Latest IPO step: Scribe Therapeutics, Inc. filed its final IPO prospectus, ticker SCTX (424B4, 2026-07-27).
IPO filings: 424B4, 2026-07-27, S-1/A, 2026-07-20, S-1/A, 2026-07-10, S-1, 2026-07-02; ticker SCTX on Nasdaq Global Market.
Keep reading
More on Scribe Therapeutics, Inc. and the records around it.
Scribe Therapeutics, Inc. elsewhere on the record
- 5%+ stake filings Aug 2026
Companies that share a holder
- ELI LILLY & Co also filed stake reports on 5 other companies: TRex Bio, Inc. (Oct 2026), Ionetix Corp / DE / (Jul 2026), ProQR Therapeutics N.V. (Jul 2026)
- Avoro Capital Advisors LLC also filed stake reports on 18 other companies: Arrowhead Pharmaceuticals, Inc. (Aug 2026), Avalo Therapeutics, Inc. (Aug 2026), Hemab Therapeutics Holdings, Inc. (Aug 2026)
- ORBIMED ADVISORS LLC also filed stake reports on 38 other companies: Aspen Neuroscience, Inc. (Nov 2026), ArriVent BioPharma, Inc. (Oct 2026), ADARx Pharmaceuticals, Inc. (Oct 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/scribe-therapeutics